DAVID P. SOUTHWELL
Profile
First Name
: DAVID
Middle Name
: P.
Last Name
: SOUTHWELL
Related Companies
Titles
Company Name
Related People
DIRECTOR
RICHARD ALDRICH, NEIL ALMSTEAD, NEIL ALMSTEAD, PH.D, WILLIAM BAIRD, III, AXEL BOLTE, MARK E. BOULDING, SOREN CARLSEN, CARL GOLDFISCHER, EMILY HILL, CLAUDIA HIRAWAT, ALLAN S. JACOBSON, ALLAN JACOBSON, PH.D., MATTHEW KLEIN, MATTHEW B. KLEIN, MATTHEW B. KLEIN, M.D., ADAM KOPPEL, MICHAEL KRANDA, GEOFFREY MCDONOUGH, LANGDON L. MILLER, LANGON L. MILLER, STEPANIE S. OKEY, STEPHANIE S. OKEY, DEEPA PAKIANATHAN, ERIC PAUWELS, STUART W. PELTZ, EMMA REEVE, MICHAEL SCHMERTZLER, MARY SMITH, MARCIO SOUZA, GLENN D. STEELE JR., M.D., PH.D., GLENN D. STEELE, JR., PETER SVENNILSON, DAWN SVORONOS, CHRISTINE UTTER, ALETHIA YOUNG, JEROME B. ZELDIS, JEROME B. ZELDIS, M.D., PH.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-04-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-04-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-08-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-05-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-03-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-01-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-05-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2009-12-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
2009-09-22
